Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 44

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Fluid-Phase Pinocytosis of Native Low Density Lipoprotein Promotes Murine M-CSF Differentiated Macrophage Foam Cell Formation

Barthwal, Manoj K., Anzinger, Joshua J., Xu, Qing, Bohnacker, Thomas, Wymann, Matthias P., Kruth, Howard S. · 2013 · PLoS ONE

Abstract

During atherosclerosis, low-density lipoprotein (LDL)-derived cholesterol accumulates in macrophages to form foam cells. Macrophage uptake of LDL promotes foam cell formation but the mechanism mediating this process is not clear. The present study investigates the mechanism of LDL uptake for macrophage colony-stimulating factor (M-CSF)-differentiated murine bone marrow-derived macrophages. LDL receptor-null (LDLR-/-) macrophages incubated with LDL showed non-saturable accumulation of cholesterol that did not down-regulate for the 24 h examined. Incubation of LDLR-/- macrophages with increasing concentrations of (125)I-LDL showed non-saturable macrophage LDL uptake. A 20-fold excess of unlabeled LDL had no effect on (125)I-LDL uptake by wild-type macrophages and genetic deletion of the macrophage scavenger receptors CD36 and SRA did not affect (125)I-LDL uptake, showing that LDL uptake occurred by fluid-phase pinocytosis independently of receptors. Cholesterol accumulation was inhibited approximately 50% in wild-type and LDLR-/- mice treated with LY294002 or wortmannin, inhibitors of all classes of phosphoinositide 3-kinases (PI3K). Time-lapse, phase-contrast microscopy showed that macropinocytosis, an important fluid-phase uptake pathway in macrophages, was blocked almost completely by PI3K inhibition with wortmannin. Pharmacological inhibition of the class I PI3K isoforms alpha, beta, gamma or delta did not affect macrophage LDL-derived cholesterol accumulation or macropinocytosis. Furthermore, macrophages from mice expressing kinase-dead class I PI3K beta, gamma or delta isoforms showed no decrease in cholesterol accumulation or macropinocytosis when compared with wild-type macrophages. Thus, non-class I PI3K isoforms mediated macropinocytosis in these macrophages. Further characterization of the components necessary for LDL uptake, cholesterol accumulation, and macropinocytosis identified dynamin, microtubules, actin, and vacuolar type H(+)-ATPase as contributing to uptake. However, Pak1, Rac1, and Src-family kinases, which mediate fluid-phase pinocytosis in certain other cell types, were unnecessary. In conclusion, our findings provide evidence that targeting those components mediating macrophage macropinocytosis with inhibitors may be an effective strategy to limit macrophage accumulation of LDL-derived cholesterol in arteries.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0058054

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Macropinosome formation is M-CSF dependent. A and B. Wild-type macrophages were differentiated with M-CSF for 7 days and visualized by phase-contrast microscopy following the treatments described below. Macrophages differentiated with M-CSF were pretreated 30 min with DMSO drug vehicle (A), or 5 µM of cFMS (i.e., M-CSF receptor) tyrosine kinase inhibitor, GW2580 (B). Pretreatment was carried out without either serum or M-CSF. Withdrawal of M-CSF caused disappearance of the macrophage vacuoles. Subsequently, these macrophage cultures were treated 30 min with fresh serum-free medium containing M-CSF (50 ng/ml) without (A) or with GW2580 (B). Macrophages treated with M-CSF without GW2580 showed numerous vacuoles shown to be macropinosomes in Video S1. In contrast, there was complete inhibition of macropinosome formation when macrophage cultures were treated with GW2580 (also see Video S2). Scale bar in B = 75 µm and also applies to A. (C) Wild-type macrophages were incubated 24 h with 1 mg/ml LDL without or with 5 µM GW2580, and then cholesterol accumulation was assessed. Macrophages incubated without LDL had 111±3 nmol cholesterol/mg protein. ** = p<0.01.
Figure 1 Macropinosome formation is M-CSF dependent. A and B. Wild-type macrophages were differentiated with M-CSF for 7 days and visualized by phase-contrast microscopy following the treatments described below. Macrophages differentiated with M-CSF were pretreated 30 min with DMSO drug vehicle (A), or 5 µM of cFMS (i.e., M-CSF receptor) tyrosine kinase inhibitor, GW2580 (B). Pretreatment was carried out without either serum or M-CSF. Withdrawal of M-CSF caused disappearance of the macrophage vacuoles. Subsequently, these macrophage cultures were treated 30 min with fresh serum-free medium containing M-CSF (50 ng/ml) without (A) or with GW2580 (B). Macrophages treated with M-CSF without GW2580 showed numerous vacuoles shown to be macropinosomes in Video S1. In contrast, there was complete inhibition of macropinosome formation when macrophage cultures were treated with GW2580 (also see Video S2). Scale bar in B = 75 µm and also applies to A. (C) Wild-type macrophages were incubated 24 h with 1 mg/ml LDL without or with 5 µM GW2580, and then cholesterol accumulation was assessed. Macrophages incubated without LDL had 111±3 nmol cholesterol/mg protein. ** = p<0.01.CC0 · PubMed Central
Figure 2 Macrophage uptake of 125I-LDL is non-saturable. A. LDLR−/− macrophages were incubated with 1 mg/ml of LDL for 0–24 h and cholesterol accumulation was then assessed. B. LDLR−/− macrophages were incubated 24 h with increasing concentrations of 125I-LDL, and then 125I-LDL uptake was assessed. Uptake values represent the sum of cell-associated and degraded 125I-LDL. The range of cell-associated and degraded 125I-LDL was 7–13% and 87–93%, respectively.
Figure 2 Macrophage uptake of 125I-LDL is non-saturable. A. LDLR−/− macrophages were incubated with 1 mg/ml of LDL for 0–24 h and cholesterol accumulation was then assessed. B. LDLR−/− macrophages were incubated 24 h with increasing concentrations of 125I-LDL, and then 125I-LDL uptake was assessed. Uptake values represent the sum of cell-associated and degraded 125I-LDL. The range of cell-associated and degraded 125I-LDL was 7–13% and 87–93%, respectively.CC0 · PubMed Central
Figure 3 Fluid-phase pinocytosis mediates LDL uptake. (A) Wild-type macrophages were incubated 6 h with either 25 µg/ml 125I-LDL alone, or 25 µg/ml 125I-LDL and 500 µg/ml unlabeled LDL. CD36 KO macrophages (ΔCD36) and SRA KO macrophages (ΔSRA) macrophages were incubated 6 h with 25 µg/ml 125I-LDL alone. (B) Wild-type macrophages were incubated 6 h with either 25 µg/ml 125I-AcLDL alone, or 25 µg/ml 125I-AcLDL and 500 µg/ml unlabeled AcLDL. CD36 KO macrophages (ΔCD36) and SRA KO macrophages (ΔSRA) macrophages were incubated 6 h with 25 µg/ml 125I-AcLDL alone. Incubations were performed in serum-free medium containing 50 ng/ml M-CSF. Uptake values represent the sum of cell-associated and degraded 125I-labeled lipoprotein. The range of cell-associated and degraded 125I-LDL was 17–21% and 79–83%, respectively. The range of cell-associated and degraded 125I-AcLDL was 16–18% and 82–84%, respectively. 125I-LDL uptake was not competed with excess unlabeled LDL consistent with fluid-phase pinocytosis mediating uptake. Statistical tests compare each treatment group with wild-type macrophages incubated with 25 µg/ml 125I-AcLDL. * = p<0.05. ** = p<0.01. *** = p<0.001. There was no statistical difference between macrophage groups incubated with 125I-LDL.
Figure 3 Fluid-phase pinocytosis mediates LDL uptake. (A) Wild-type macrophages were incubated 6 h with either 25 µg/ml 125I-LDL alone, or 25 µg/ml 125I-LDL and 500 µg/ml unlabeled LDL. CD36 KO macrophages (ΔCD36) and SRA KO macrophages (ΔSRA) macrophages were incubated 6 h with 25 µg/ml 125I-LDL alone. (B) Wild-type macrophages were incubated 6 h with either 25 µg/ml 125I-AcLDL alone, or 25 µg/ml 125I-AcLDL and 500 µg/ml unlabeled AcLDL. CD36 KO macrophages (ΔCD36) and SRA KO macrophages (ΔSRA) macrophages were incubated 6 h with 25 µg/ml 125I-AcLDL alone. Incubations were performed in serum-free medium containing 50 ng/ml M-CSF. Uptake values represent the sum of cell-associated and degraded 125I-labeled lipoprotein. The range of cell-associated and degraded 125I-LDL was 17–21% and 79–83%, respectively. The range of cell-associated and degraded 125I-AcLDL was 16–18% and 82–84%, respectively. 125I-LDL uptake was not competed with excess unlabeled LDL consistent with fluid-phase pinocytosis mediating uptake. Statistical tests compare each treatment group with wild-type macrophages incubated with 25 µg/ml 125I-AcLDL. * = p<0.05. ** = p<0.01. *** = p<0.001. There was no statistical difference between macrophage groups incubated with 125I-LDL.CC0 · PubMed Central
Figure 4 Macropinocytosis is inhibited by PI3K and actin polymerization inhibitors. Wild-type macrophages differentiated with M-CSF were pretreated 30 min with the drugs indicated below but without serum and M-CSF. Then, macrophages were treated 30 min with fresh serum-free medium containing M-CSF (50 ng/ml) in the presence of either DMSO vehicle (A), 100 nM wortmannin (B), 4 µg/ml cytochalasin D (C), or 50 µM LY294002 (D), and then examined by phase-contrast microscopy. Arrows indicate macropinosomes. Scale bar in A = 75 µm and applies to all. (Also see Videos S5, S6, S7, S8).
Figure 4 Macropinocytosis is inhibited by PI3K and actin polymerization inhibitors. Wild-type macrophages differentiated with M-CSF were pretreated 30 min with the drugs indicated below but without serum and M-CSF. Then, macrophages were treated 30 min with fresh serum-free medium containing M-CSF (50 ng/ml) in the presence of either DMSO vehicle (A), 100 nM wortmannin (B), 4 µg/ml cytochalasin D (C), or 50 µM LY294002 (D), and then examined by phase-contrast microscopy. Arrows indicate macropinosomes. Scale bar in A = 75 µm and applies to all. (Also see Videos S5, S6, S7, S8).CC0 · PubMed Central
Figure 5 Wild-type and LDL−/− macrophages incubated with LDL accumulate similar levels of cholesterol. Wild-type and LDLR−/− macrophages were incubated with 1 mg/ml LDL for 24 h and then total cholesterol accumulation was assessed. The baseline cholesterol levels for wild-type and LDLR−/− macrophages were 107±10 nmol cholesterol/mg protein and 122±9 nmol cholesterol/mg protein, respectively.
Figure 5 Wild-type and LDL−/− macrophages incubated with LDL accumulate similar levels of cholesterol. Wild-type and LDLR−/− macrophages were incubated with 1 mg/ml LDL for 24 h and then total cholesterol accumulation was assessed. The baseline cholesterol levels for wild-type and LDLR−/− macrophages were 107±10 nmol cholesterol/mg protein and 122±9 nmol cholesterol/mg protein, respectively.CC0 · PubMed Central
Figure 6 LDL-derived cholesterol accumulation occurs independently of class I PI3K isoforms. Cholesterol accumulation after 24 h-incubation without or with 1 mg/ml LDL was assessed in M-CSF differentiated macrophages cultured from wild-type, PI3Kγ-KI, PI3Kβ-KI, and PI3Kδ-KI mice.
Figure 6 LDL-derived cholesterol accumulation occurs independently of class I PI3K isoforms. Cholesterol accumulation after 24 h-incubation without or with 1 mg/ml LDL was assessed in M-CSF differentiated macrophages cultured from wild-type, PI3Kγ-KI, PI3Kβ-KI, and PI3Kδ-KI mice.CC0 · PubMed Central
Figure 7 Macrophage macropinosome formation is dependent on dynamin and vacuolar type H(+)-ATPase. Wild-type M-CSF differentiated macrophages were pretreated 30 min with the indicated drugs but without serum and M-CSF. Subsequently, macrophages cultures were treated 30 min with fresh serum-free medium containing M-CSF (50 ng/ml) and either drug vehicle (A), 80 µM dynasore (B), 500 nM bafilomycin A1 (C), or 100 µM NSC23766 (D). Then, macropinosome formation was assessed by phase-contrast microscopy. Scale bar in A = 75 µm and applies to all. (Also see Videos S9, S10, S11, S12, S13, S14).
Figure 7 Macrophage macropinosome formation is dependent on dynamin and vacuolar type H(+)-ATPase. Wild-type M-CSF differentiated macrophages were pretreated 30 min with the indicated drugs but without serum and M-CSF. Subsequently, macrophages cultures were treated 30 min with fresh serum-free medium containing M-CSF (50 ng/ml) and either drug vehicle (A), 80 µM dynasore (B), 500 nM bafilomycin A1 (C), or 100 µM NSC23766 (D). Then, macropinosome formation was assessed by phase-contrast microscopy. Scale bar in A = 75 µm and applies to all. (Also see Videos S9, S10, S11, S12, S13, S14).CC0 · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 47

  1. NR Webb, 2007, Macrophage-derived foam cells in atherosclerosis: lessons from murine models and implications for therapy, Curr Drug Targets, 8, 1249, 10.2174/138945007783220597 · DOI
  2. M Febbraio, 2000, Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice, J Clin Invest, 105, 1049, 10.1172/JCI9259 · DOI · Paper page
  3. VR Babaev, 2000, Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A, Arterioscler Thromb Vasc Biol, 20, 2593, 10.1161/01.ATV.20.12.2593 · DOI · Paper page
  4. VV Kunjathoor, 2002, Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages, J Biol Chem, 277, 49982, 10.1074/jbc.M209649200 · DOI · Paper page
  5. JJ Manning-Tobin, 2009, Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice, Arterioscler Thromb Vasc Biol, 29, 19, 10.1161/ATVBAHA.108.176644 · DOI · Paper page
  6. KJ Moore, 2005, Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice, J Clin Invest, 115, 2192, 10.1172/JCI24061 · DOI · Paper page
  7. JJ Anzinger, 2010, Native low-density lipoprotein uptake by macrophage colony-stimulating factor-differentiated human macrophages is mediated by macropinocytosis and micropinocytosis, Arterioscler Thromb Vasc Biol, 30, 2022, 10.1161/ATVBAHA.110.210849 · DOI
  8. HS Kruth, 2011, Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particles, Curr Opin Lipidol, 22, 386, 10.1097/MOL.0b013e32834adadb · DOI
  9. HS Kruth, 2002, Macrophage foam cell formation with native low density lipoprotein, J Biol Chem, 277, 34573, 10.1074/jbc.M205059200 · DOI · Paper page
  10. HS Kruth, 2005, Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density lipoprotein, J Biol Chem, 280, 2352, 10.1074/jbc.M407167200 · DOI · Paper page
  11. B Zhao, 2006, Constitutive receptor-independent low density lipoprotein uptake and cholesterol accumulation by macrophages differentiated from human monocytes with macrophage-colony-stimulating factor (M-CSF), J Biol Chem, 281, 15757, 10.1074/jbc.M510714200 · DOI
  12. JA Swanson, 1995, Macropinocytosis, Trends Cell Biol, 5, 424, 10.1016/S0962-8924(00)89101-1 · DOI · Paper page
  13. J Mercer, 2009, Virus entry by macropinocytosis, Nat Cell Biol, 11, 510, 10.1038/ncb0509-510 · DOI · Paper page
  14. M Amyere, 2002, Origin, originality, functions, subversions and molecular signalling of macropinocytosis, Int J Med Microbiol, 291, 487, 10.1078/1438-4221-00157 · DOI · Paper page
  15. SK Clinton, 1992, Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis, Am J Pathol, 140, 301
  16. T Rajavashisth, 1998, Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice, J Clin Invest, 101, 2702, 10.1172/JCI119891 · DOI · Paper page
  17. JH Qiao, 1997, Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice, Am J Pathol, 150, 1687
  18. T Murayama, 1999, Intraperitoneal administration of anti-c-fms monoclonal antibody prevents initial events of atherogenesis but does not reduce the size of advanced lesions in apolipoprotein E-deficient mice, Circulation, 99, 1740, 10.1161/01.CIR.99.13.1740 · DOI
  19. Z Shaposhnik, 2010, Arterial colony stimulating factor-1 influences atherosclerotic lesions by regulating monocyte migration and apoptosis, J Lipid Res, 51, 1962, 10.1194/jlr.M005215 · DOI
  20. EL Racoosin, 1992, M-CSF-induced macropinocytosis increases solute endocytosis but not receptor-mediated endocytosis in mouse macrophages, J Cell Sci 102 (Pt, 4), 867, 10.1242/jcs.102.4.867 · DOI · Paper page
  21. S Yoshida, 2009, Sequential signaling in plasma-membrane domains during macropinosome formation in macrophages, J Cell Sci, 122, 3250, 10.1242/jcs.053207 · DOI · Paper page
  22. N Araki, 2003, Phosphoinositide-3-kinase-independent contractile activities associated with Fcgamma-receptor-mediated phagocytosis and macropinocytosis in macrophages, J Cell Sci, 116, 247, 10.1242/jcs.00235 · DOI · Paper page
  23. K Blajecka, 2011, Phosphatidylinositol 3-kinase isoforms as novel drug targets, Curr Drug Targets, 12, 1056, 10.2174/138945011795677773 · DOI
  24. JM Cleary, 2010, Development of phosphoinositide-3 kinase pathway inhibitors for advanced cancer, Curr Oncol Rep, 12, 87, 10.1007/s11912-010-0091-6 · DOI
  25. T Sasaki, 2002, Phosphoinositide 3-kinases in immunity: lessons from knockout mice, J Biochem, 131, 495, 10.1093/oxfordjournals.jbchem.a003126 · doi:10.1093/oxfordjournals.jbchem.a003126
  26. B Vanhaesebroeck, 2005, Signalling by PI3K isoforms: insights from gene-targeted mice, Trends Biochem Sci, 30, 194, 10.1016/j.tibs.2005.02.008 · DOI · Paper page
  27. C Buono, 2007, Liver X receptors inhibit human monocyte-derived macrophage foam cell formation by inhibiting fluid-phase pinocytosis of LDL, J Lipid Res, 48, 2411, 10.1194/jlr.M700170-JLR200 · DOI
  28. K Kasahara, 2007, Role of Src-family kinases in formation and trafficking of macropinosomes, J Cell Physiol, 211, 220, 10.1002/jcp.20931 · DOI
  29. AJ Ridley, 1992, The small GTP-binding protein rac regulates growth factor-induced membrane ruffling, Cell, 70, 401, 10.1016/0092-8674(92)90164-8 · DOI · Paper page
  30. HF Hoff, 1978, Apo B concentration in the normal human aorta, Biochem Biophys Res Commun, 85, 1424, 10.1016/0006-291X(78)91162-2 · DOI
  31. EB Smith, 1983, Low-density lipoprotein concentration in interstitial fluid from human atherosclerotic lesions. Relation to theories of endothelial damage and lipoprotein binding, Biochim Biophys Acta, 754, 249, 10.1016/0005-2760(83)90139-X · DOI
  32. Smith EB (1990) Transport, interactions and retention of plasma proteins in the intima: the barrier function of the internal elastic lamina. Eur Heart J 11 Suppl E: 72–81. · DOI
  33. H Cao, 2007, Dynamin 2 mediates fluid-phase micropinocytosis in epithelial cells, J Cell Sci, 120, 4167, 10.1242/jcs.010686 · DOI
  34. J Huynh, 2012, CSF-1 receptor signalling from endosomes mediates the sustained activation of Erk1/2 and Akt in macrophages, Cell Signal, 24, 1753, 10.1016/j.cellsig.2012.04.022 · DOI
  35. CL Chen, 2009, Inhibitors of clathrin-dependent endocytosis enhance TGFbeta signaling and responses, J Cell Sci, 122, 1863, 10.1242/jcs.038729 · DOI
  36. S Dharmawardhane, 2000, Regulation of macropinocytosis by p21-activated kinase-1, Mol Biol Cell, 11, 3341, 10.1091/mbc.11.10.3341 · DOI · Paper page
  37. P Liberali, 2008, The closure of Pak1-dependent macropinosomes requires the phosphorylation of CtBP1/BARS, EMBO J, 27, 970, 10.1038/emboj.2008.59 · DOI · Paper page
  38. S Fumoto, 2009, Rac-mediated macropinocytosis is a critical route for naked plasmid DNA transfer in mice, Mol Pharm, 6, 1170, 10.1021/mp900042p · DOI
  39. M Mettlen, 2006, Src triggers circular ruffling and macropinocytosis at the apical surface of polarized MDCK cells, Traffic, 7, 589, 10.1111/j.1600-0854.2006.00412.x · DOI
  40. A Veithen, 1996, v-Src induces constitutive macropinocytosis in rat fibroblasts, J Cell Sci 109 (Pt, 8), 2005, 10.1242/jcs.109.8.2005 · DOI
  41. JJ Anzinger, 2012, Murine bone marrow-derived macrophages differentiated with GM-CSF become foam cells by PI3Kgamma-dependent fluid-phase pinocytosis of native LDL, J Lipid Res, 53, 34, 10.1194/jlr.M018887 · DOI
  42. E Hirsch, 2000, Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation, Science, 287, 1049, 10.1126/science.287.5455.1049 · DOI · Paper page
  43. E Patrucco, 2004, PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects, Cell, 118, 375, 10.1016/j.cell.2004.07.017 · DOI · Paper page
  44. J Folch, 1957, A simple method for the isolation and purification of total lipides from animal tissues, J Biol Chem, 226, 497, 10.1016/S0021-9258(18)64849-5 · DOI · Paper page
  45. W Gamble, 1978, Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells, J Lipid Res, 19, 1068, 10.1016/S0022-2275(20)40693-5 · DOI · Paper page
  46. OH Lowry, 1951, Protein measurement with the Folin phenol reagent, J Biol Chem, 193, 265, 10.1016/S0021-9258(19)52451-6 · DOI · Paper page
  47. JL Goldstein, 1983, Receptor-mediated endocytosis of low-density lipoprotein in cultured cells, Methods Enzymol, 98, 241, 10.1016/0076-6879(83)98152-1 · DOI · Paper page

Cited by

See all 44

Metadata

Authors
Barthwal, M. K., Anzinger, J. J., Xu, Q., Bohnacker, T., Wymann, M. P., & Kruth, H. S.
Venue
PLoS ONE
Published
2013-03-11
Volume
8
Issue
3
Pages
e58054
ISSN
1932-6203
Cited by
44
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fluid-Phase Pinocytosis of Native Low Density Lipoprotein Promotes Murine M-CSF Differentiated Macrophage Foam Cell Formation. https://app.cochat.ai/papers/10.1371/journal.pone.0058054
The paper
Barthwal, M. K., Anzinger, J. J., Xu, Q., Bohnacker, T., Wymann, M. P., & Kruth, H. S. (2013). Fluid-Phase Pinocytosis of Native Low Density Lipoprotein Promotes Murine M-CSF Differentiated Macrophage Foam Cell Formation. PLoS ONE. https://doi.org/10.1371/journal.pone.0058054

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.